查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1603804

2030 年生物陶瓷市场预测：按类型、材料类型、形式、应用、最终用户和地区进行的全球分析

Bioceramics Market Forecasts to 2030 - Global Analysis By Type (Bio-inert, Bio-active and Bio-resorbable), Material Type (Alumina, Zirconia, Hydroxyapatite (HAp) and Other Materials), Form, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2024年全球生物陶瓷市场规模将达82亿美元，预计2030年将达到133亿美元，预测期内复合年增长率为8.3%。

生物陶瓷是专为牙科和医疗应用而製造的陶瓷材料。由于其高生物相容性，在人体内使用是安全的。它们与活体组织良好相互作用的能力使其在组织工程、牙齿修復和整形外科植入中很受欢迎。生物陶瓷中使用的材料分为三类：惰性、生物活性和生物可吸收，通常包括羟磷石灰、氧化锆、氧化铝和磷酸钙陶瓷。

根据美国整形外科) 的数据，2019 年大约进行了 125 万例涉及髋关节和膝关节的 TJA 手术。

肌肉骨骼疾病增加

骨关节炎、骨质疏鬆症和牙齿问题等肌肉骨骼疾病的日益普及正在推动对生物陶瓷的需求。随着世界人口老化，对整形外科植入、牙科修补和骨移植的需求不断增加。生物陶瓷是这些应用的理想选择，因为它们具有生物相容性并与天然骨组织整合。因此，退化性关节疾病和牙科疾病的负担不断增加，推动了市场的成长。

耐用性问题

儘管生物陶瓷具有许多优点，但与传统金属植入相比，其长期耐用性和机械强度仍然令人担忧。陶瓷材料很脆，在高应力下容易断裂。这限制了其在特定负载应用中的使用。一些外科医生对于广泛使用生物陶瓷犹豫不决，因为随着时间的推移可能会出现植入失败或失效的可能性。

医疗科技的进步

3D列印、奈米技术和组织工程等医疗技术的快速进步正在为生物陶瓷创造新的机会。 3D 列印可以创建具有复杂多孔结构的自订形状植入。奈米结构生物陶瓷表现出增强的生物和机械性能。使用生物陶瓷支架的组织工程方法有望用于骨骼和软骨再生。这些技术进步正在扩大生物陶瓷材料在医疗设备中的潜在应用并提高其性能。

严格的监管要求

医疗设备业面临严格的法律规范，尤其是生物陶瓷等植入材料。新生物陶瓷产品获得监管部门的核准需要进行广泛的测试和临床试验，这既耗时又昂贵。不同地区不断变化的法规和标准增加了复杂性。严格的品管和文件要求增加了製造成本。漫长的核准流程和高监管壁垒威胁着生物陶瓷领域的市场成长和创新。

COVID-19 的影响：

COVID-19 大流行严重扰乱了 2020 年的生物陶瓷市场。选择性手术和牙科治疗被推迟，减少了对整形外科和牙科植入的需求。供应链中断影响了原材料的供应和生产。然而，随着医疗保健活动正常化，市场已表现出弹性并正在復苏。此次疫情凸显了感染控制的重要性，并可能增加人们对抗菌生物陶瓷的兴趣。总体而言，虽然COVID-19造成了短期挫折，但预计不会对生物陶瓷市场的长期成长轨迹产生任何持久的负面影响。

惰性领域预计将在预测期内成为最大的领域

由于其卓越的机械性能和化学稳定性，预计惰性领域在预测期内将占据最大的市场占有率。这些材料广泛用于承重整形外科植入，例如髋关节和膝关节假体。由于与身体组织的反应性低，适合长期植入。骨关节炎盛行率的增加和全关节重建手术数量的增加正在推动对惰性生物陶瓷的需求。其临床记录和完善的製造流程有助于其市场主导地位。

磷酸钙陶瓷产业预计在预测期内复合年增长率最高。

预计磷酸钙陶瓷产业在预测期内将以最高复合年增长率成长。这些材料与天然骨的矿物质含量非常相似，并具有出色的生物活性和骨整合能力。它越来越多地用于人工植牙、骨移植物和金属植入的涂层。对再生医学和组织工程的日益关注正在推动对磷酸钙支架的研究。促进骨骼生长和重塑的磷酸钙支架对各种整形外科和牙科应用具有吸引力，推动了市场的快速扩张。

比最大的地区

预计欧洲在预测期内将主导生物陶瓷市场占有率。该地区庞大的老龄化人口和高昂的医疗保健支出正在推动对整形外科和牙科植入的需求。欧洲拥有大量专注于生物陶瓷技术创新的主要医疗设备製造商和研究机构。德国和法国等国家的植入治疗优惠报销政策正在支持市场成长。该地区先进的医疗保健基础设施和较早采用新医疗技术有助于其在生物陶瓷市场的领导地位。

复合年增长率最高的地区：

预计北美将成为生物陶瓷市场成长率最高的地区。该地区在生物材料和再生医学领域的积极研发活动正在推动生物陶瓷技术的创新。牙科和整形外科疾病盛行率的增加以及医疗保健意识的提高正在推动需求。主要市场参与者的存在以及新型生物陶瓷产品正在进行的临床试验正在促进市场的快速扩张。对先进医疗植入的投资增加以及向微创手术的转变进一步加速了北美市场的成长。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球生物陶瓷市场：依类型

  • 惰性
  • 生物活性
  • 生物可吸收的

第六章全球生物陶瓷市场：依材料类型

  • 氧化铝
  • 氧化锆
  • 羟磷石灰(HAp)
  • 玻璃陶瓷
    • 生物活性玻璃
    • 玻璃增强陶瓷
  • 磷酸钙陶瓷
    • 磷酸三钙 (TCP)
    • 双相磷酸钙 (BCP)
  • 其他材料类型

第七章全球生物陶瓷市场：依形式

  • 粉末
  • 液体

第八章全球生物陶瓷市场：依应用分类

  • 整形外科
  • 牙科
  • 组织工程
  • 药物输送
  • 其他用途

第九章全球生物陶瓷市场：依最终用户分类

  • 医院
  • 诊所
  • 调查机构
  • 其他最终用户

第十章全球生物陶瓷市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、合作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 公司概况

  • CoorsTek, Inc.
  • Kyocera Corporation
  • Morgan Advanced Materials Plc
  • CeramTec GmbH
  • Tosoh Ceramics Co., Ltd.
  • Institut Straumann AG
  • Berkeley Advanced Biomaterials
  • DSM
  • Stryker Corporation
  • Dentsply Sirona
  • Zimmer-Biomet Holdings
  • 3M Company
  • BONESUPPORT
  • DePuy Synthes
  • Amedica Corporation
  • Nobel Biocare Services AG
  • CAM Bioceramics
  • Collagen Matrix Inc.
Product Code: SMRC27826

According to Stratistics MRC, the Global Bioceramics Market is accounted for $8.2 billion in 2024 and is expected to reach $13.3 billion by 2030, growing at a CAGR of 8.3% during the forecast period. Bioceramics are ceramic materials created especially for dental and medical applications. They are safe to use inside the human body because of their biocompatibility. Their ability to interact well with biological tissues makes them popular in tissue engineering, dental restorations, and orthopedic implants. The materials used to make bioceramics, which fall into three categories-bioinert, bioactive, and bioresorbable-usually include hydroxyapatite, zirconia, alumina, and calcium phosphate ceramics.

According to the American Academy of Orthopaedic Surgeons (AAOS) in 2019, approximately 1.25 million TJA procedures, including hip and knee arthroplasties, were performed.

Market Dynamics:

Driver:

Rising incidence of musculoskeletal conditions

The increasing prevalence of musculoskeletal disorders like osteoarthritis, osteoporosis, and dental issues is driving demand for bioceramics. As the global population ages, there is growing need for orthopedic implants, dental prosthetics, and bone grafts. Bioceramics offer excellent biocompatibility and integration with natural bone tissue, making them ideal for such applications. The rising burden of degenerative joint diseases and dental problems is thus propelling market growth.

Restraint:

Durability concerns

While bioceramics offer many advantages, there are still some concerns about their long-term durability and mechanical strength compared to traditional metallic implants. Ceramic materials can be brittle and prone to fracture under high stress. This limits their use in certain load-bearing applications. The potential for implant failure or breakage over time makes some surgeons hesitant to use bioceramics extensively.

Opportunity:

Advancements in medical technology

Rapid progress in medical technologies like 3D printing, nanotechnology, and tissue engineering is creating new opportunities for bioceramics. 3D printing allows for the fabrication of custom-shaped implants with intricate porous structures. Nanostructured bioceramics exhibit enhanced biological and mechanical properties. Tissue engineering approaches using bioceramic scaffolds show promise for regenerating bone and cartilage. These technological advancements are expanding the potential applications and improving the performance of bioceramic materials in medical devices.

Threat:

Stringent regulatory requirements

The medical device industry faces rigorous regulatory oversight, particularly for implantable materials like bioceramics. Obtaining regulatory approvals for new bioceramic products involves extensive testing and clinical trials, which can be time-consuming and expensive. Changing regulations and standards across different regions add complexity. Stringent quality control and documentation requirements increase manufacturing costs. The lengthy approval process and high regulatory barriers pose a threat to market growth and innovation in the bioceramics sector.

Covid-19 Impact:

The COVID-19 pandemic significantly disrupted the bioceramics market in 2020. Elective surgeries and dental procedures were postponed, reducing demand for orthopedic and dental implants. Supply chain disruptions affected raw material availability and production. However, the market showed resilience and is recovering as healthcare activities normalize. The pandemic highlighted the importance of infection control, potentially boosting interest in antimicrobial bioceramics. Overall, while causing short-term setbacks, COVID-19 is not expected to have lasting negative impacts on the long-term growth trajectory of the bioceramics market.

The bio-inert segment is expected to be the largest during the forecast period

The bio-inert segment is projected to hold the largest market share over the forecasted timeframe due to their excellent mechanical properties and chemical stability. These materials are widely used in load-bearing orthopedic implants like hip and knee replacements. Their low reactivity with body tissues makes them suitable for long-term implantation. The growing prevalence of osteoarthritis and rising number of joint replacement surgeries are driving demand for bio-inert bioceramics. Their proven clinical track record and established manufacturing processes contribute to their market dominance.

The calcium phosphate ceramics segment is expected to have the highest CAGR during the forecast period

During the projection period, the calcium phosphate ceramics segment is expected to grow at the highest CAGR. These materials closely resemble the mineral component of natural bone, offering superior bioactivity and osseointegration. They are increasingly used in dental implants, bone grafts, and coatings for metallic implants. The rising focus on regenerative medicine and tissue engineering is boosting research into calcium phosphate scaffolds. Their ability to promote bone growth and remodeling makes them attractive for various orthopedic and dental applications, driving rapid market expansion.

Region with largest share:

Europe is expected to dominate the bioceramics market share during the forecast period. The region's large and aging population, coupled with high healthcare expenditure, drives demand for orthopedic and dental implants. Europe has a strong presence of leading medical device manufacturers and research institutions focusing on bioceramic innovations. Favorable reimbursement policies for implant procedures in countries like Germany and France support market growth. The region's advanced healthcare infrastructure and early adoption of new medical technologies contribute to its market leadership in bioceramics.

Region with highest CAGR:

North America is projected to exhibit the highest growth rate in the bioceramics market. The region's robust research and development activities in biomaterials and regenerative medicine are driving innovation in bioceramic technologies. The increasing prevalence of dental and orthopedic disorders, coupled with rising healthcare awareness, is boosting demand. The presence of key market players and ongoing clinical trials for novel bioceramic products contribute to rapid market expansion. Growing investments in advanced medical implants and the shift towards minimally invasive surgeries are further accelerating market growth in North America..

Key players in the market

Some of the key players in Bioceramics Market include CoorsTek, Inc., Kyocera Corporation, Morgan Advanced Materials Plc, CeramTec GmbH, Tosoh Ceramics Co., Ltd., Institut Straumann AG, Berkeley Advanced Biomaterials, DSM, Stryker Corporation, Dentsply Sirona, Zimmer-Biomet Holdings, 3M Company, BONESUPPORT, DePuy Synthes, Amedica Corporation, Nobel Biocare Services AG, CAM Bioceramics, and Collagen Matrix Inc.

Key Developments:

In October 2024, Straumann Group has increased its stake in Createch Medical and acquired shares in botiss biomaterials. These acquisitions enhance Straumann's capabilities in CAD/CAM prosthetic solutions and regenerative biomaterials for dental implantology.

In August 2024, Kyoto Sangyo University, Kyocera, and Photocross Collaborate on World-First Ground-Based Telescope Innovations. To realize a reflecting telescope equipped with a large, lightweight fine cordierite mirror, a world's first achievement, and to develop ceramic reflective optical systems for infrared astronomical observation instruments, Kyoto Sangyo University, Kyocera Corporation (hereafter "Kyocera"), and Photocross, Co., Ltd. (hereafter "Photocross") have reached a comprehensive and detailed agreement. This agreement outlines each party's roles and responsibilities, the project timeline, and the expected outcomes, ensuring a coordinated and effective collaboration.

In June 2024, CeramTec introduced Sinalit, a silicon nitride-based substrate at the PCIM Europe trade fair. This product expands their portfolio of high-performance ceramics for medical technology.

Types Covered:

  • Bio-inert
  • Bio-active
  • Bio-resorbable

Material Types Covered:

  • Alumina
  • Zirconia
  • Hydroxyapatite (HAp)
  • Glass Ceramics
  • Calcium Phosphate Ceramics
  • Other Material Types

Forms Covered:

  • Powder
  • Liquid

Applications Covered:

  • Orthopedics
  • Dentistry
  • Tissue Engineering
  • Drug Delivery
  • Other Applications

End Users Covered:

  • Hospitals
  • Clinics
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioceramics Market, By Type

  • 5.1 Introduction
  • 5.2 Bio-inert
  • 5.3 Bio-active
  • 5.4 Bio-resorbable

6 Global Bioceramics Market, By Material Type

  • 6.1 Introduction
  • 6.2 Alumina
  • 6.3 Zirconia
  • 6.4 Hydroxyapatite (HAp)
  • 6.5 Glass Ceramics
    • 6.5.1 Bioactive Glass
    • 6.5.2 Glass-Reinforced Ceramics
  • 6.6 Calcium Phosphate Ceramics
    • 6.6.1 Tricalcium Phosphate (TCP)
    • 6.6.2 Biphasic Calcium Phosphate (BCP)
  • 6.7 Other Material Types

7 Global Bioceramics Market, By Form

  • 7.1 Introduction
  • 7.2 Powder
  • 7.3 Liquid

8 Global Bioceramics Market, By Application

  • 8.1 Introduction
  • 8.2 Orthopedics
  • 8.3 Dentistry
  • 8.4 Tissue Engineering
  • 8.5 Drug Delivery
  • 8.6 Other Applications

9 Global Bioceramics Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Clinics
  • 9.4 Research Institutes
  • 9.5 Other End Users

10 Global Bioceramics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 CoorsTek, Inc.
  • 12.2 Kyocera Corporation
  • 12.3 Morgan Advanced Materials Plc
  • 12.4 CeramTec GmbH
  • 12.5 Tosoh Ceramics Co., Ltd.
  • 12.6 Institut Straumann AG
  • 12.7 Berkeley Advanced Biomaterials
  • 12.8 DSM
  • 12.9 Stryker Corporation
  • 12.10 Dentsply Sirona
  • 12.11 Zimmer-Biomet Holdings
  • 12.12 3M Company
  • 12.13 BONESUPPORT
  • 12.14 DePuy Synthes
  • 12.15 Amedica Corporation
  • 12.16 Nobel Biocare Services AG
  • 12.17 CAM Bioceramics
  • 12.18 Collagen Matrix Inc.

List of Tables

  • Table 1 Global Bioceramics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Bioceramics Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Bioceramics Market Outlook, By Bio-inert (2022-2030) ($MN)
  • Table 4 Global Bioceramics Market Outlook, By Bio-active (2022-2030) ($MN)
  • Table 5 Global Bioceramics Market Outlook, By Bio-resorbable (2022-2030) ($MN)
  • Table 6 Global Bioceramics Market Outlook, By Material Type (2022-2030) ($MN)
  • Table 7 Global Bioceramics Market Outlook, By Alumina (2022-2030) ($MN)
  • Table 8 Global Bioceramics Market Outlook, By Zirconia (2022-2030) ($MN)
  • Table 9 Global Bioceramics Market Outlook, By Hydroxyapatite (HAp) (2022-2030) ($MN)
  • Table 10 Global Bioceramics Market Outlook, By Glass Ceramics (2022-2030) ($MN)
  • Table 11 Global Bioceramics Market Outlook, By Bioactive Glass (2022-2030) ($MN)
  • Table 12 Global Bioceramics Market Outlook, By Glass-Reinforced Ceramics (2022-2030) ($MN)
  • Table 13 Global Bioceramics Market Outlook, By Calcium Phosphate Ceramics (2022-2030) ($MN)
  • Table 14 Global Bioceramics Market Outlook, By Tricalcium Phosphate (TCP) (2022-2030) ($MN)
  • Table 15 Global Bioceramics Market Outlook, By Biphasic Calcium Phosphate (BCP) (2022-2030) ($MN)
  • Table 16 Global Bioceramics Market Outlook, By Other Material Types (2022-2030) ($MN)
  • Table 17 Global Bioceramics Market Outlook, By Form (2022-2030) ($MN)
  • Table 18 Global Bioceramics Market Outlook, By Powder (2022-2030) ($MN)
  • Table 19 Global Bioceramics Market Outlook, By Liquid (2022-2030) ($MN)
  • Table 20 Global Bioceramics Market Outlook, By Application (2022-2030) ($MN)
  • Table 21 Global Bioceramics Market Outlook, By Orthopedics (2022-2030) ($MN)
  • Table 22 Global Bioceramics Market Outlook, By Dentistry (2022-2030) ($MN)
  • Table 23 Global Bioceramics Market Outlook, By Tissue Engineering (2022-2030) ($MN)
  • Table 24 Global Bioceramics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 25 Global Bioceramics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 26 Global Bioceramics Market Outlook, By End User (2022-2030) ($MN)
  • Table 27 Global Bioceramics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 28 Global Bioceramics Market Outlook, By Clinics (2022-2030) ($MN)
  • Table 29 Global Bioceramics Market Outlook, By Research Institutes (2022-2030) ($MN)
  • Table 30 Global Bioceramics Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.